At the turn of the century the average life span of women in the United States was 48 years, compared with 46 years in men. Since then the life expectancy in women has almost doubled and is now 79 years, compared with 73 years in men. Because of the gender gap in life expectancy, women currently comprise close to two thirds of the population older than age 65 and three fourths of the population older than age 85. The fastest-growing age group in the United States is the population aged 85 years and older. As a result, it is estimated that at the beginning of the 21st century, women will outnumber men by 2 to 1 in the age groups older than 65 and by 3 to 1 in the population older than 85. The reasons for the dramatic increase in overall life expectancy are thought to be related to the control of infectious diseases and progress in the treatment of chronic diseases such as diabetes and cardiovascular disease. The reasons for the disparity in life expectancy in women and in men are less well established but are thought to be primarily biologic.
Despite a dramatic decline in mortality rates for heart disease that has occurred in both sexes over the past two decades, heart disease remains the leading cause of death in women and accounts for one third of all deaths in women. Heart disease occurs about 10 years later in women than in men. This delayed onset is thought to be due primarily to the protective effect of estrogens in premenopausal women and accounts for the fact that 90% of heart disease mortality in women occurs after the menopause. There are significant racial and ethnic differences in mortality among women. Black women are more likely to die of heart disease than white women up to age 75; thereafter, death rates are higher in white women. In contrast, Hispanic and Native American women have significantly lower rates of death from heart disease. Evidence suggests that heart disease, once it develops, is more serious in women than in men, resulting in higher mortality rates. In addition to biologic factors, the poorer survival of women may be due to the older age and increased prevalence of co-morbid conditions in women at the time of diagnosis, as well as to less well-defined social factors that influence the diagnosis and treatment of heart disease in women.
Cancer is the second leading cause of death in women and is the most common cause of premature death. The mortality rate for all cancers combined in women has changed little during the last part of the 20th century. Major advances in the diagnosis and treatment of cervical and uterine cancers in women have been offset by an increase in mortality rates for lung and breast cancer. Although breast cancer is still the most common cancer diagnosed in women, lung cancer is now the leading cause of cancer deaths. Unfortunately, most of these deaths can be attributed to cigarette smoking. Whereas deaths from lung cancer in men have begun to decline due to a decrease in male cigarette use, death rates for women increased between 1990 and 1995 and are expected to continue to rise.
Breast cancer is the second leading cause of cancer deaths in women. Although the incidence of breast cancer has risen over the past decade, mortality rates have remained relatively stable. This disparity is thought to be caused partly by the widespread use of screening mammography and the detection of earlier-stage cancers that have a more favorable prognosis. There are significant age and racial differences in breast cancer mortality. Declining mortality rates in younger women have been offset by an increase in mortality rates in older women. Although breast cancer incidence rates are 12% lower in black than in white women, mortality rates are 15% higher in black women. Reasons for racial differences in breast cancer incidence and mortality are unclear but may be related to socioeconomic and biologic factors as well as certain health behaviors, such as participation in screening mammography. Although it has been shown that breast cancer screening with mammography and clinical breast examination decreases mortality from breast cancer in women older than age 50 by approximately 30%, less than 50% of American women aged 50 years and older receive regular screening; and this figure is considerably lower in poor, minority, and elderly women. Read more: risk factors for breast cancer.
Although stroke-related deaths have declined by almost 60% in the United States over the past 25 years, deaths from stroke still account for approximately 6% of all deaths in women and rank third as a cause of mortality. Striking racial differences exist in stroke mortality: death rates in black women are almost twice those for white women. Most of the stroke deaths in women result from thromboembolic disease and occur in older women. However, subarachnoid hemorrhage, the least common form of stroke, is more common in women than in men and contributes to stroke mortality, particularly in younger women.
Death rates from chronic pulmonary diseases have increased steadily for both women and men during the past 25 years; however, the increase has been greater in women. Because this increase has been linked to patterns in cigarette smoking, the increase in death rates in women for pulmonary disease, as well as for lung cancer, are expected to continue to rise. Death rates from pneumonia and influenza closely parallel pulmonary-related deaths and vary over time based on the epidemiology of these acute illnesses.
Diabetes has consistently ranked as a leading cause of death in women. Moreover, the reported death rate from diabetes most likely underestimates the impact of this disease on mortality because of its strong association with other life-threatening medical conditions, such as cardiovascular disease, stroke, and kidney failure. It is estimated that diabetes affects one in six women older than age 45; however, prevalence rates are higher in black, Hispanic, and Native American women. Separate from disease-related death rates, diabetes is a significant cause of morbidity and, in women of childbearing age, has important adverse effects on pregnancy outcome, resulting in an increased risk of fetal and perinatal mortality as well as congenital malformations.
Although HIV infection is not one of the 10 leading causes of death in women overall, it is responsible for the largest percent increase in death rates of all the major causes of mortality. HIV-related mortality rates are nine times higher for black than for white women. As a result, HIV infection ranks third as the leading cause of death in black women ages 15 to 24 and first in the age group 25 to 44 and in some geographic areas has become the number one cause of death. As the epidemiology of this epidemic changes, with heterosexual transmission accounting for an increasing proportion of HIV infection in women, these rates are expected to continue to rise.
Mortality rates alone do not provide a complete picture of women’s health status. Although women live longer than men, overall measures of health status are worse in women. Based on estimates from the National Health Interview Survey (NHIS), more women than men report symptoms or seek care for acute medical conditions, such as respiratory and digestive disorders, and are more disabled by these self-limited illnesses, as measured by number of days spent in bed or days lost from work. In addition, several chronic conditions occur more frequently in women and cause significant disability, such as arthritis, thyroid disease, migraine, bladder disorders, gastritis, colitis, and chronic constipation. Data from other sources show that affective disorders, especially major depressive episodes, and the anxiety disorders are significantly more prevalent in women. Most importantly, women’s self-perceived health status is poorer than men’s. According to estimates from the NHIS, only 36% of women describe their health as excellent, compared with 41% of men.